glp 1 statistics GLP-1 Antagonists Increase Plan Drug Spend - What's Next The No-Hunger Games: How GLP-1
Description
Finally, the desire to eat any type of food was decreased by exogenous administrated GLP-1.
This success is influencing broader industry trends
Between 30 million and 50 million US adults could be taking a GLP-1 by 2034. In December 2024, 1.9 million prescriptions of GLP-1s to treat obesity (as opposed to diabetes, for example) were filled, nearly quadruple the number YoY, per IQVIA
Results Seven trials (6609 participants) were included
